Astera Labs (NASDAQ:ALAB) Shares Down 2.1% – Time to Sell?

Astera Labs, Inc. (NASDAQ:ALAB) traded down 2.1% during mid-day trading on Wednesday . The stock traded as low as $267.01 and last traded at $274.13. 2,841,044 shares traded hands during trading, a decline of 47% from the average daily volume of 5,322,209 shares. The stock had previously closed at $279.91.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently weighed in on ALAB shares. Susquehanna upped their price target on shares of Astera Labs from $230.00 to $275.00 and gave the stock a “neutral” rating in a research note on Friday, July 31st. Citigroup reaffirmed a “buy” rating on shares of Astera Labs in a research report on Wednesday, July 29th. Evercore reiterated an “outperform” rating and set a $297.00 target price on shares of Astera Labs in a research note on Tuesday, May 19th. Weiss Ratings reissued a “hold (c)” rating on shares of Astera Labs in a report on Tuesday, August 18th. Finally, Jefferies Financial Group increased their price target on shares of Astera Labs from $270.00 to $450.00 and gave the stock a “buy” rating in a research report on Wednesday, August 5th. One research analyst has rated the stock with a Strong Buy rating, twelve have assigned a Buy rating and eight have assigned a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $348.33.

Astera Labs Trading Down 2.1%

The firm’s 50 day moving average is $337.19 and its two-hundred day moving average is $251.85. The firm has a market cap of $47.56 billion, a P/E ratio of 135.71 and a beta of 3.78.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, topping analysts’ consensus estimates of $0.69 by $0.11. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The company had revenue of $392.40 million for the quarter, compared to analyst estimates of $360.85 million. During the same quarter last year, the firm posted $0.44 earnings per share. Astera Labs’s revenue was up 104.5% compared to the same quarter last year. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Analysts predict that Astera Labs, Inc. will post 2.7 EPS for the current fiscal year.

Insider Transactions at Astera Labs

In other news, CEO Jitendra Mohan sold 90,630 shares of the company’s stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $340.35, for a total value of $30,845,920.50. Following the transaction, the chief executive officer owned 1,266,665 shares of the company’s stock, valued at approximately $431,109,432.75. This represents a 6.68% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, COO Sanjay Gajendra sold 90,630 shares of the firm’s stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the transaction, the chief operating officer directly owned 1,119,038 shares in the company, valued at approximately $380,864,583.30. This represents a 7.49% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last 90 days, insiders sold 406,745 shares of company stock valued at $158,581,158. 10.40% of the stock is owned by insiders.

Institutional Investors Weigh In On Astera Labs

A number of hedge funds have recently made changes to their positions in ALAB. Greenleaf Trust boosted its position in Astera Labs by 1.8% during the 2nd quarter. Greenleaf Trust now owns 2,000 shares of the company’s stock worth $966,000 after buying an additional 36 shares during the period. Glenmede Trust Co. NA lifted its stake in shares of Astera Labs by 2.7% in the 1st quarter. Glenmede Trust Co. NA now owns 1,909 shares of the company’s stock valued at $209,000 after purchasing an additional 51 shares during the period. Keating Financial Advisory Services Inc. bought a new position in shares of Astera Labs during the 2nd quarter worth approximately $25,000. Lido Advisors LLC increased its stake in Astera Labs by 0.5% in the fourth quarter. Lido Advisors LLC now owns 12,297 shares of the company’s stock valued at $2,046,000 after purchasing an additional 57 shares in the last quarter. Finally, Archer Investment Corp acquired a new stake in Astera Labs in the second quarter valued at approximately $30,000. 60.47% of the stock is currently owned by institutional investors and hedge funds.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.